Stephanie Andrews

2.4k total citations · 1 hit paper
25 papers, 978 citations indexed

About

Stephanie Andrews is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Stephanie Andrews has authored 25 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Stephanie Andrews's work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Melanoma and MAPK Pathways (6 papers). Stephanie Andrews is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Melanoma and MAPK Pathways (6 papers). Stephanie Andrews collaborates with scholars based in United States, United Kingdom and Germany. Stephanie Andrews's co-authors include Ronald C. DeConti, Adil Daud, Vernon K. Sondak, P. Urbas, Adam I. Riker, Pamela N. Münster, Jane L. Messina, Richard Heller, Kenneth E. Ugen and Daniel M. Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Stephanie Andrews

25 papers receiving 955 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

2008 503 citations Adil Daud, Ronald C. DeConti et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Stephanie Andrews

Since Specialization

Citations

This map shows the geographic impact of Stephanie Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Andrews more than expected).

Fields of papers citing papers by Stephanie Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Andrews. The network helps show where Stephanie Andrews may publish in the future.

Co-authorship network of co-authors of Stephanie Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Andrews. A scholar is included among the top collaborators of Stephanie Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Andrews. Stephanie Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Causal relationship between snoring and Alzheimer's disease: Longitudinal cohort and Mendelian Randomization study 2024 ·Sleep Medicine ·(unknown), Stephanie Andrews, Kristine Yaffe, Yue Leng	2
2	Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial 2023 ·Cancer ·Areej El‐Jawahri, Marlise R. Luskin, Joseph A. Greer, Lara Traeger, (unknown), (unknown), Stephanie Andrews, (unknown), (unknown), Richard Newcomb, Nneka N. Ufere, Amir T. Fathi, Gabriela Hobbs, Andrew M. Brunner, Gregory A. Abel, Richard M. Stone, Daniel J. DeAngelo, Martha Wadleigh, Jennifer S. Temel	9
3	Preliminary Investigation of Workplace-Provided Compressed Mindfulness-Based Stress Reduction with Pediatric Medical Social Workers 2017 ·Health & Social Work ·(unknown), Lisa Mische Lawson, Stephanie Andrews, (unknown), (unknown)	17
4	Challenges of Toxicity Management in Immuno-Oncology 2017 ·Journal of the National Comprehensive Cancer Network ·Stephanie Andrews	2
5	New-onset toxicity with programmed death-1 inhibitor rechallenge 2016 ·Melanoma Research ·(unknown), Stephanie Andrews, (unknown), (unknown)	2
6	What do people need to be resilient in the current NHS? 2015 ·Clinical Psychology Forum ·Stephanie Andrews, Fiona Thorne	2
7	Primer on Immuno-Oncology and Immune Response 2014 ·Clinical journal of oncology nursing ·(unknown), Kathleen Madden, Stephanie Andrews	7
8	Characteristics and management of immune-related adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma 2012 ·Cancer Management and Research ·Stephanie Andrews	57
9	Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma 2011 ·British Journal of Cancer ·Alain P. Algazi, Jeffrey S. Weber, Stephanie Andrews, P. Urbas, Pamela N. Münster, Ronald C. DeConti, Justin H. Hwang, Vernon K. Sondak, Jane L. Messina, Timothy H. McCalmont, Adil Daud	33
10	Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma 2010 ·Cancer Chemotherapy and Pharmacology ·Adil Daud, Christine Xu, Wen‐Jen Hwu, P. Urbas, Stephanie Andrews, Nicholas E. Papadopoulos, Leslie Carstensen Floren, Antoine Yver, Ronald C. DeConti, Vernon K. Sondak	17
11	Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma 2010 ·British Journal of Cancer ·Ronald C. DeConti, Alain P. Algazi, Stephanie Andrews, P. Urbas, (unknown), Detlef Stoeckigt, Leslie Carstensen Floren, Justin H. Hwang, Jeffrey S. Weber, Vernon K. Sondak, Adil Daud	12
12	Phase II trial of sagopilone (ZK-EPO), a novel synthetic epothilone, with significant activity in metastatic melanoma 2009 ·Journal of Clinical Oncology ·Adil Daud, Jeffrey S. Weber, P. Urbas, Stephanie Andrews, (unknown), Vernon K. Sondak, Ronald C. DeConti	6
13	Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma breakdown → 2008 ·Journal of Clinical Oncology ·Adil Daud, Ronald C. DeConti, Stephanie Andrews, P. Urbas, Adam I. Riker, Vernon K. Sondak, Pamela N. Münster, Daniel M. Sullivan, Kenneth E. Ugen, Jane L. Messina, Richard Heller	503
14	Elevated Serum Tobramycin Concentrations After Treatment with Tobramycin Inhalation in a Preterm Infant 2008 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Ibrahim Abdulhamid, (unknown), Stephanie Andrews, (unknown), Victoria Tutag Lehr	11
15	The safety and tolerability of galantamine in patients with epilepsy and memory difficulties 2008 ·Epilepsy & Behavior ·H. Randall Griffith, Roy C. Martin, Stephanie Andrews, A. LeBron Paige, (unknown), Edward Faught, Timothy E. Welty	14
16	Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating Factor 2008 ·Journal of Clinical Oncology ·Adil Daud, Noweeda Mirza, Brianna Lenox, Stephanie Andrews, P. Urbas, (unknown), Ji‐Hyun Lee, Vernon K. Sondak, Adam I. Riker, Ronald C. DeConti, Dmitry I. Gabrilovich	135
17	Phase II trial of sagopilone (ZK-EPO), a novel epothilone, in patients with metastatic melanoma 2008 ·Journal of Clinical Oncology ·(unknown), Ronald C. DeConti, P. Urbas, Stephanie Andrews, Vernon K. Sondak, (unknown), Jeffrey S. Weber, Adil Daud	8
18	340 POSTER Gene therapy with plasmid IL-12 delivered by electroporation in patients with malignant melanoma: results of first human Phase I trial 2006 ·European Journal of Cancer Supplements ·Richard Heller, (unknown), Jane L. Messina, Stephanie Andrews, P. Urbas, Kenneth E. Ugen, Chris Puleo, (unknown), Adam I. Riker, Adil Daud	2
19	Overall and Progression-Free Survival in Metastatic Melanoma: Analysis of a Single-Institution Database 2006 ·Cancer Control ·(unknown), Stephanie Andrews, Roohi Ismail‐Khan, Pamela N. Münster, Steven Brem, Jeff King, Douglas S. Reintgen, Vernon K. Sondak, Adil Daud	18
20	Phase II trial of karenitecin (BNP1350) in malignant: Clinical and translational study 2004 ·Journal of Clinical Oncology ·F. H. Hausheer, Elmer Berghorn, (unknown), Daniel M. Sullivan, Barbara A. Centeno, (unknown), Ronald C. DeConti, Adil Daud, Patricia Sullivan, Stephanie Andrews	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact